Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.
Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S. Giustina A, et al. Among authors: marazuela m. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz096. doi: 10.1210/clinem/dgz096. J Clin Endocrinol Metab. 2020. PMID: 31606735 Free article.
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy.
Marazuela M, Lucas T, Alvarez-Escolá C, Puig-Domingo M, de la Torre NG, de Miguel-Novoa P, Duran-Hervada A, Manzanares R, Luque-Ramírez M, Halperin I, Casanueva FF, Bernabeu I. Marazuela M, et al. Eur J Endocrinol. 2009 Apr;160(4):535-42. doi: 10.1530/EJE-08-0705. Epub 2009 Jan 15. Eur J Endocrinol. 2009. PMID: 19147599
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly.
Bernabeu I, Alvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, de Miguel-Novoa P, Fernandez-Rodriguez E, Halperin I, Loidi L, Casanueva FF, Marazuela M. Bernabeu I, et al. Among authors: marazuela m. J Clin Endocrinol Metab. 2010 Jan;95(1):222-9. doi: 10.1210/jc.2009-1630. Epub 2009 Oct 22. J Clin Endocrinol Metab. 2010. PMID: 19850678
Long-term treatment with pegvisomant for acromegaly: a 10-year experience.
Ramos-Leví AM, Bernabeu I, Álvarez-Escolá C, Aller J, Lucas T, de Miguel P, Rodríguez-Cañete L, Sampedro-Núñez MA, Halperin I, Puig-Domingo M, Marazuela M. Ramos-Leví AM, et al. Among authors: marazuela m. Clin Endocrinol (Oxf). 2016 Apr;84(4):540-50. doi: 10.1111/cen.12993. Epub 2016 Jan 26. Clin Endocrinol (Oxf). 2016. PMID: 26662620
Expert document on management of acromegaly.
Bernabeu I, Cámara R, Marazuela M, Puig Domingo M. Bernabeu I, et al. Among authors: marazuela m. Endocrinol Diabetes Nutr (Engl Ed). 2018 Oct;65(8):428-437. doi: 10.1016/j.endinu.2018.05.012. Epub 2018 Jul 4. Endocrinol Diabetes Nutr (Engl Ed). 2018. PMID: 30244765 English, Spanish.
Precision medicine in the treatment of acromegaly.
Puig-Domingo M, Marazuela M. Puig-Domingo M, et al. Among authors: marazuela m. Minerva Endocrinol. 2019 Jun;44(2):169-175. doi: 10.23736/S0391-1977.18.02937-1. Epub 2018 Dec 7. Minerva Endocrinol. 2019. PMID: 30531695 Review.
215 results